Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project.
about
The Human Skeletal Muscle Proteome Project: a reappraisal of the current literatureRecommendations for the conduct of clinical trials for drugs to treat or prevent sarcopeniaSarcopenia and sarcopenic obesity: do they predict inferior oncologic outcomes after gastrointestinal cancer surgery?GWAS analysis of handgrip and lower body strength in older adults in the CHARGE consortiumDietary protein is associated with musculoskeletal health independently of dietary pattern: the Framingham Third Generation StudyThe Need for Standardized Assessment of Muscle Quality in Skeletal Muscle Function Deficit and Other Aging-Related Muscle Dysfunctions: A Symposium Report.Physical activity and sarcopenic obesity: definition, assessment, prevalence and mechanism.The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates.A feasibility study of implementing grip strength measurement into routine hospital practice (GRImP): study protocol.Association of Low Lean Mass With Frailty and Physical Performance: A Comparison Between Two Operational Definitions of Sarcopenia-Data From the Berlin Aging Study II (BASE-II).Declines in Strength and Mortality Risk Among Older Mexican Americans: Joint Modeling of Survival and Longitudinal Data.Angiotensin-Converting Enzyme Inhibitors and Parameters of Sarcopenia: Relation to Muscle Mass, Strength and Function: Data from the Berlin Aging Study-II (BASE-II).Using relative handgrip strength to identify children at risk of sarcopenic obesity.Sarcopenia and physical frailty: two sides of the same coinClinical strategies and animal models for developing senolytic agents.It is not just muscle mass: a review of muscle quality, composition and metabolism during ageing as determinants of muscle function and mobility in later life.Impaired skeletal health and neuromuscular function among amphetamine users in clinical treatment.Strength and function response to clinical interventions of older women categorized by weakness and low lean mass using classifications from the Foundation for the National Institute of Health sarcopenia projectSarcopenia-related parameters and incident disability in older persons: results from the "invecchiare in Chianti" study"Skeletal muscle function deficit" in a nationally representative British birth cohort in early old age.Sarcopenia and impairment in cognitive and physical performance.Protein intake and muscle function in older adultsPrediction of Mobility Limitations after Hospitalization in Older Medical Patients by Simple Measures of Physical Performance Obtained at Admission to the Emergency Department.Development of Novel Methods to Define Deficits in Appendicular Lean Mass Relative to Fat Mass.Predictive Values of the New Sarcopenia Index by the Foundation for the National Institutes of Health Sarcopenia Project for Mortality among Older Korean Adults.Gender differences in the association between grip strength and mortality in older adults: results from the KORA-age study.Growth Charts for Muscular Strength Capacity With Quantile Regression.Successful aging: Advancing the science of physical independence in older adults.The Predictive Value of the EWGSOP Definition of Sarcopenia: Results From the InCHIANTI Study.The AMPK-related kinase SNARK regulates muscle mass and myocyte survival.Evaluation of the Usefulness of Consensus Definitions of Sarcopenia in Older Men: Results from the Observational Osteoporotic Fractures in Men Cohort Study.Operationalization of the physical frailty & sarcopenia syndrome: rationale and clinical implementationSarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999-2004Method of quantifying 3D strain distribution in skeletal muscle using cine phase contrast MRISleep, Muscle Mass and Muscle Function in Older PeopleMuscle Weakness Thresholds for Prediction of Diabetes in AdultsClinically relevant weakness in diverse populations of older adults participating in the International Mobility in Aging Study.Letter to the editor: results from a Web-based survey to identify dynapenia screening tools and risk factors.Skeletal Muscle Function Deficits in the Elderly: Current Perspectives on Resistance Training.Sarcopenia among patients receiving hemodialysis: weighing the evidence.
P2860
Q28068399-DD72F864-4F49-4494-910C-78B6E058027EQ28069408-8E40C981-7B0B-48BC-801E-F81938C3C502Q28079809-7237A654-DE3E-4D35-980F-80C4CC848AFDQ28596242-640B767F-4DDC-409A-98B5-87C7236F33CDQ28778627-E274548F-4E6F-4CBE-83DB-0F35EB85C21DQ30235428-E0D5CE2A-0B8E-40DF-A65B-7A8EA8A90707Q30239891-8F7EDF83-6FAF-4730-96A7-0C3A5ED47373Q30576350-C7EFB02A-FECE-4940-A561-90A6EB498F60Q30831803-77755D13-B100-4F04-8401-BB2A6DF4C940Q30886859-6F017FFD-D747-4FE6-80D8-AF1FB733641DQ31063115-C8118D0A-F7D4-4D8D-9945-0DBD256891C9Q31132903-0D919B6C-3F6F-421C-8888-CBC6F833A346Q33719092-2D76B70F-4477-4CAF-BE2E-C055800FBC0EQ33958411-46B02EE0-5D45-413F-83F0-61C0B284B76FQ34450706-92099DAB-D6B0-47D5-9446-9B3395DEB758Q34454559-18FDDC6B-FCAC-4248-923A-9419AACC9C95Q34499413-E1429888-B1B4-435A-8079-D5C4D939A1E3Q35029369-CE6FC0AA-1699-49CC-8974-E0191DC752FDQ35221405-BA54FFF0-D754-444D-A6FA-EDA7139D980EQ35286483-4D8EC2C8-E3AA-42F7-AB0F-16EECE0D585FQ35298183-7D08E05F-9498-46A4-8AF4-CBDFD5FFC8CAQ35376863-59A2279A-D14B-4931-B31D-80D9C3628FA0Q36022091-E06CF9BB-D11B-4B9B-8DE7-4E460B3C5C64Q36159451-4A524D99-0BF0-4823-955B-AF2262B1C130Q36188713-3D31F760-2B15-406B-B69D-295F8B493925Q36208463-9F495BC8-8476-4953-A2FB-8B3F10878A9DQ36307559-93A53080-A769-48C9-9B7B-74747B2F0FEAQ36322590-8D16F5CC-30A4-440C-9FD3-2D23B36BF596Q36492369-687F53A7-97AA-458F-AB41-3AC312C11F8DQ36515098-D52FE66A-B89F-4BBE-AF07-C41C640F5A74Q36539322-1EFA037B-6111-4220-BCE5-D668BC405F88Q36738480-DD6BC5F5-CB7A-4AC5-98BF-182846507A6BQ36781283-C2099DE1-53EF-46A9-9D6C-8A29EDC41543Q36818439-BE49B5A2-D021-4DFC-A417-E866F077D566Q36882862-FE8D46DE-D4AF-4E24-ACE3-594FCCF056D7Q36892459-92F3981E-35DF-43FD-AA6D-8BD3BB9A7214Q37219506-D7536A75-A0B1-4E5F-B019-384F8DBB81F0Q37233089-4B049190-6DE1-4580-8CFB-1F32B9BE97B4Q37636834-79DF3E6E-4BCA-425E-B0D2-86925B2FB3F0Q37667482-9688DD8C-3027-45C8-B948-A88D2AD437D1
P2860
Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Criteria for clinically releva ...... lth (FNIH) sarcopenia project.
@en
Criteria for clinically releva ...... National Institutes of Health
@nl
type
label
Criteria for clinically releva ...... lth (FNIH) sarcopenia project.
@en
Criteria for clinically releva ...... National Institutes of Health
@nl
prefLabel
Criteria for clinically releva ...... lth (FNIH) sarcopenia project.
@en
Criteria for clinically releva ...... National Institutes of Health
@nl
P2093
P2860
P356
P1476
Criteria for clinically releva ...... lth (FNIH) sarcopenia project.
@en
P2093
Anne M Kenny
Dawn E Alley
Douglas P Kiel
Jack M Guralnik
Katherine W Peters
Luigi Ferrucci
Maren S Fragala
Maria T Vassileva
Michelle D Shardell
Peggy M Cawthon
P2860
P304
P356
10.1093/GERONA/GLU012
P407
P577
2014-05-01T00:00:00Z